Stock Footage0:28
Bridgeman Arts

UNITED STATES 1960s: View of pills on conveyor belt.

Pre-K - Higher Ed
UNITED STATES 1960s: View of pills on conveyor belt / Pile of pills, zoom out / Pills in machine / Close up of tablets falling / View of labels through magnifying glass / Labels through magnifying glass / Gears turning / Close up of...
News Clip7:30
Curated Video

Study: More Than 1 Million People Will Die From Opioids In This Decade

Higher Ed
Researchers are calling for better regulation, industry reform and new methods of managing pain after projecting high overdose numbers.
News Clip11:22
Bloomberg

Toby Cosgrove on Obamacare, Drug Prices, Tom Price

Higher Ed
Dec.08 -- Cleveland Clinic President and CEO Dr. Toby Cosgrove has been asked to join President-Elect Donald Trump’s economic advisory panel, chaired by Blackstone’s Stephen Schwarzman. In an interview with David Gura on “Bloomberg...
News Clip3:22
Curated Video

How Coronavirus Could Slow Down The U.S. Drug Supply

Higher Ed
The United States relies on overseas factories for some of the key ingredients of vital medications, and shortages could impact medication supplies.
News Clip2:38
Bloomberg

DFC Chief Boehler Reacts to Probe Into Kodak Loan

Higher Ed
Aug.14 -- Adam Boehler, U.S. International Development Finance Corp. chief executive officer, comments on Congress and the Securities and Exchange Commission investigating the federal agency's $765 million loan to Eastman Kodak Co. and...
News Clip5:59
Bloomberg

Reshaping the Pharma Industry

Higher Ed
June 28 -- Jami Rubin, partner at Goldman Sachs, discusses the impact of Brexit on the pharmaceutical industry, research and development in the sector and companies she's keeping an eye on. She speaks to Bloomberg's Joe Weisenthal, Matt...
News Clip1:54
Curated Video

Moderna Seeks To Be 1st With COVID Shot For Kids Under 5

Higher Ed
Moderna is asking U.S. regulators to approve its COVID-19 vaccine for kids under 5 — the only group not yet eligible for vaccination.
News Clip1:48
Bloomberg

Tilray Shares Soar as CEO Touts Growth Potential

Higher Ed
Sep.19 -- Tilray Inc. shares set up for a third-straight day of gains after the company received clearance from the U.S. DEA to import medical marijuana to supply a clinical trial in California. Bloomberg Intelligence's Ken Shea reports...
News Clip0:49
Curated Video

Pfizer, NYU Developing COVID-19 Vaccine With Hopeful September Release

Higher Ed
Researchers are trying to build a vaccine that uses messenger RNA to help the human body produce antibodies.
News Clip1:07
Curated Video

Vaccine Alliance To Fund Global Stockpile Of Ebola Vaccines

Higher Ed
It's expected to cost Gavi $178 million.
News Clip3:41
Bloomberg

How Big Pharma Uses Charity Programs to Cover Price Hikes

Higher Ed
May 23 -- Bloomberg Businessweek's Ben Elgin explains how patient-assistance funds operate. While they cover much or all of the out-of-pocket drug costs for some of the 40 million Americans receiving Medicare, they also give drug...
News Clip5:16
Bloomberg

Glaxo Can't Rule Out More U.S. Pharma Regulation: Witty

Higher Ed
November 8 -- Glaxo benefited most from currency moves in 3Q, with the weaker pound increasing sales by 9% while a 10% boost is expected for the full year. Glaxo CEO Andrew Witty tells Francine Lacqua speaking from Mumbai on "Bloomberg...
News Clip0:27
Curated Video

Study Finds Magic Mushrooms May Help Fight Depression

Higher Ed
Researchers saw improvements in patients after just six weeks, but say more tests are needed to find if it's more effective than pharmaceuticals.
News Clip2:20
Curated Video

How Fast Can J&J Vaccine Be Produced?

Higher Ed
Johnson & Johnson moved slower in their clinical trials than Moderna and Pfizer, in part, to focus on manufacturing.
News Clip0:29
Curated Video

Pfizer Agrees To Let Other Companies Manufacture Its COVID-19 Pill

Higher Ed
The drugmaker won't receive royalties on sales in low-income countries and will waive royalties where the virus is still a public health emergency.
News Clip0:21
Curated Video

Johnson & Johnson Ordered To Pay $302M In Pelvic Mesh Case

Higher Ed
An appeals court judge found that the company made misleading and potentially harmful statements in advertisements and instructional brochures.
News Clip2:40
AFP News Agency

CLEAN : South Africa debates legalisation of rhino trade

9th - Higher Ed
CLEAN : South Africa debates legalisation of rhino trade
News Clip2:34
AFP News Agency

CLEAN : FILE: S Africa wont seek to legalise rhino horn trade govt

9th - Higher Ed
CLEAN : FILE: S Africa wont seek to legalise rhino horn trade govt
News Clip3:45
Bloomberg

Qiming Venture's Kuang Likes Healthcare, Bio Tech

Higher Ed
Jun.25 -- As part of our Venture China series, Qiming Venture Partners founding partner Duane Kuang told Bloomberg's Tom Mackenzie where he sees opportunities.
News Clip2:31
Bloomberg

Noah Holdings’s CIO Remains Constructive on China’s A-Share Market

Higher Ed
Aug.19 -- William Ma, chief investment officer at Noah Holdings, discusses the revamp of China’s interest rate framework, what it means for equity markets and where he’s finding opportunity. He speaks on “Bloomberg Markets: China Open.”
News Clip3:37
Curated Video

Trump pushes for speed on virus vaccine

Higher Ed
President Donald Trump and members of his Cabinet are meeting at the White House with executives of 10 pharmaceutical companies to learn ways to speed the development of a vaccine for the coronavirus.
News Clip2:01
Bloomberg

Kodak Will Help Make Medicines to Fight Covid, Says Trump

Higher Ed
Jul.28 -- Eastman Kodak Co. shares more than tripled Tuesday on plans to secure a $765 million government loan to help produce ingredients used in key generic medicines to fight the coronavirus. The money could provide a lifeline to the...
News Clip4:08
Bloomberg

Asian Equities a Screaming Buy for Investors, Says Daiwa Capital's Kitney

Higher Ed
Sep.04 -- Paul Kitney, APAC chief equity strategist at Daiwa Capital Markets, discusses Asian equities and where he sees markets heading from here. He speaks on "Bloomberg Markets: Asia."